Time for cooperation in health economics among the modelling community.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health.PharmacoEconomics · 2024
   Article
2. Transparency in Decision Modelling: What, Why, Who and How?PharmacoEconomics · 2019
   Review
3. The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.PharmacoEconomics · 2019
   Article
4. Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics.PharmacoEconomics · 2019
   Review
5. Ahead of Our Time: Collaboration in Modeling Then and Now.PharmacoEconomics · 2017
   Article
6. Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.PharmacoEconomics · 2017
   Article
7. Model Registration: A Call to Action.PharmacoEconomics - open · 2017
   Article
8. Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis.Clinical and molecular allergy : CMA · 2017
   Review
9. The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.Chemotherapy research and practice · 2016
   Article
10. Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness.Advances in hematology · 2015
    Article
11. To model or not to model: lessons from two vaccinations.The European journal of health economics : HEPAC : health economics in prevention and care · 2011
    Article
12. Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study.Lung India : official organ of Indian Chest Society
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as